Addex Therapeutics Ltd
SIX:ADXN

Watchlist Manager
Addex Therapeutics Ltd Logo
Addex Therapeutics Ltd
SIX:ADXN
Watchlist
Price: 0.0772 CHF -3.02% Market Closed
Market Cap: 14.2m CHF
Have any thoughts about
Addex Therapeutics Ltd?
Write Note

Addex Therapeutics Ltd
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Addex Therapeutics Ltd
Accounts Payable Peer Comparison

Comparables:
ADCT
ACIU
CRSP
BSLN
KURN

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Addex Therapeutics Ltd
SIX:ADXN
Accounts Payable
CHf302.4k
CAGR 3-Years
-37%
CAGR 5-Years
-31%
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Accounts Payable
$15.6m
CAGR 3-Years
43%
CAGR 5-Years
18%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Accounts Payable
CHf1.4m
CAGR 3-Years
68%
CAGR 5-Years
48%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Accounts Payable
$9.5m
CAGR 3-Years
-2%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Accounts Payable
CHf11.5m
CAGR 3-Years
29%
CAGR 5-Years
28%
CAGR 10-Years
24%
Kuros Biosciences AG
SIX:KURN
Accounts Payable
CHf2.8m
CAGR 3-Years
68%
CAGR 5-Years
33%
CAGR 10-Years
N/A

See Also

What is Addex Therapeutics Ltd's Accounts Payable?
Accounts Payable
302.4k CHF

Based on the financial report for Jun 30, 2024, Addex Therapeutics Ltd's Accounts Payable amounts to 302.4k CHF.

What is Addex Therapeutics Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
-31%

Over the last year, the Accounts Payable growth was -73%. The average annual Accounts Payable growth rates for Addex Therapeutics Ltd have been -37% over the past three years , -31% over the past five years .

Back to Top